These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20348476)

  • 1. Cutaneous mast cell tumours in dogs.
    Kupfer J
    Vet Rec; 2010 Mar; 166(13):407-8. PubMed ID: 20348476
    [No Abstract]   [Full Text] [Related]  

  • 2. Injectable treatment for mast cell tumours in dogs.
    Vet Rec; 2020 Oct; 187(7):e56. PubMed ID: 32747483
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
    Thamm DH; Weishaar KM; Charles JB; Ehrhart EJ
    Vet Comp Oncol; 2020 Jun; 18(2):169-175. PubMed ID: 31365175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous mast cell tumours in dogs.
    Polton G
    Vet Rec; 2009 Mar; 164(11):345. PubMed ID: 19287036
    [No Abstract]   [Full Text] [Related]  

  • 5. Catching cancer by the tail: new perspectives on the use of kinase inhibitors.
    Khanna C; Gordon I
    Clin Cancer Res; 2009 Jun; 15(11):3645-7. PubMed ID: 19470723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic mast cell tumour in a dog presenting with spinal pain.
    Cooper MA; Bennett PF; Laverty PH
    Aust Vet J; 2009 Apr; 87(4):157-9. PubMed ID: 19335472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mast cell tumors in dogs--diagnosis and therapy of a malignant skin tumor].
    Kessler M
    Tierarztl Prax; 1995 Apr; 23(2):172-8. PubMed ID: 7624860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
    Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
    Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer drug approved for dogs.
    J Am Vet Med Assoc; 2009 Jul; 235(2):139. PubMed ID: 19610240
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoid leucaemia in a dog after chemotherapy for mast cell sarcomas.
    Steel RJ
    Aust Vet J; 1989 Apr; 66(4):108-9. PubMed ID: 2499300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice.
    Kobie K; Kawabata M; Hioki K; Tanaka A; Matsuda H; Mori T; Maruo K
    Res Vet Sci; 2007 Apr; 82(2):239-41. PubMed ID: 16919303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is your diagnosis? Mast cell sarcoma.
    Dunn K
    J Small Anim Pract; 1997 Mar; 38(3):93, 108. PubMed ID: 9097238
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
    Pryer NK; Lee LB; Zadovaskaya R; Yu X; Sukbuntherng J; Cherrington JM; London CA
    Clin Cancer Res; 2003 Nov; 9(15):5729-34. PubMed ID: 14654558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
    Hahn KA; Legendre AM; Shaw NG; Phillips B; Ogilvie GK; Prescott DM; Atwater SW; Carreras JK; Lana SE; Ladue T; Rusk A; Kinet JP; Dubreuil P; Moussy A; Hermine O
    Am J Vet Res; 2010 Nov; 71(11):1354-61. PubMed ID: 21034327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers?
    Airley R
    Future Med Chem; 2012 Jul; 4(11):1391-4. PubMed ID: 22857529
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.
    Brière C
    Can Vet J; 2002 Aug; 43(8):620-2. PubMed ID: 12170840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
    Dobson JM; Scase TJ
    J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.